Your browser doesn't support javascript.
loading
The clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in North-East of Iran.
Sepanlou, Sadaf G; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Pharoah, Paul D; Abnet, Christian C; Brennan, Paul; Boffetta, Paolo; Dawsey, Sanford M; Kamangar, Farin.
  • Sepanlou SG; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Malekzadeh R; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Poustchi H; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Sharafkhah M; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghodsi S; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Malekzadeh F; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Etemadi A; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Pourshams A; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Pharoah PD; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Brennan P; International Agency for Research on Cancer, Lyon, France.
  • Boffetta P; The Tisch Cancer Institute, and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Dawsey SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Kamangar F; Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; Department of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, Maryland, United States of America.
PLoS One ; 10(5): e0126779, 2015.
Article en En | MEDLINE | ID: mdl-26011607
ABSTRACT

BACKGROUND:

Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran.

METHODS:

The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring

method:

sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed.

RESULTS:

A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI 0.762-0.787) in all participants, 0.772 (95% CI 0.753-0.791) in women, and 0.763 (95% CI 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed.

CONCLUSION:

The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proyectos de Investigación / Enfermedades Cardiovasculares Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proyectos de Investigación / Enfermedades Cardiovasculares Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2015 Tipo del documento: Article